(Q48000857)

English

Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

author name string

Raccah D

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Coste T

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Cameron NE

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Dufayet D

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Vague P

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Hohman TC

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Journal of Diabetes and its Complications

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

12

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

154-162

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Aldose reductase inhibitors and the complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenosine Triphosphatase Activity in Sciatic Nerve Tissue of Streptozocin-Induced Diabetic Rats with and without High Dietary Sucrose: Effect of Aldose Reductase Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

THE DETERMINATION OF NUCLEOTIDE PHOSPHORUS WITH A STANNOUS CHLORIDE-HYDRAZINE SULPHATE REAGENT

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardization of hemoglobinometry II. The hemiglobincyanide method

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin‐diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolrestat pharmacokinetics in rat peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1056-8727(97)00093-7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9618071

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48000857&oldid=2181031646"